Hygromycin A, an antibiotic previously studied for swine dysentery, shows promise in treating Lyme disease and syphilis. Research indicates its high effectiveness against Treponema pallidum, the syphilis bacterium. An American company, FlightPath, is seeking approval for human trials. The antibiotic's advantage lies in its minimal impact on the body's natural microbiome. The article, from a website focused on Lyme disease and Morgellons, highlights this potential breakthrough.
New Antibiotic Could Rid Earth Of Lyme Disease and Chronic Syphilis